Blood test monitoring of immunomodulatory therapy in inflammatory disease
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adultsGut, 2019
- Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studiesThe Lancet, 2017
- BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugsRheumatology, 2017
- Incidence, prevalence and mortality of patients with psoriasis: a U.K. population-based cohort studyBritish Journal of Dermatology, 2016
- British Association of Dermatologists’ guidelines for the safe and effective prescribing of methotrexate for skin disease 2016British Journal of Dermatology, 2016
- Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel diseaseJournal of Crohn's and Colitis, 2014
- British Association of Dermatologists’ guidelines for the safe and effective prescribing of azathioprine 2011British Journal of Dermatology, 2011
- Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomideAnnals of the Rheumatic Diseases, 2010
- Thiopurine-Induced Myelotoxicity in Patients With Inflammatory Bowel Disease: A ReviewAmerican Journal of Gastroenterology, 2008
- The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new centuryRheumatology, 2002